Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/20251

Title: Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System
Authors: Ravanidis, Stelios
Poulatsidou, Kyriaki Nepheli
Lagoudaki, R.
Touloumi, O.
Polyzoidou, E.
Lourbopoulos, A.
Nousiopoulou, E.
Theotokis, P.
Kesidou, E.
Tsalikakis, D.
Karacostas, D.
Grigoriou, M.
Chlichlia, K.
Grigoriadis, N.
Issue Date: 2015
Citation: Stem Cells Translational Medicine, 4 (12), p. 1450-1462
Abstract: Neural precursor cell (NPC) transplantation has been proposed as a therapy for multiple sclerosis (MS) and other degenerative disorders of the central nervous system (CNS). NPCs are suggested to exert immune modulation when they are transplanted in the animal model of MS, experimental autoimmune encephalomyelitis (EAE). Herein, we explore whether the effect of NPC transplantation on the clinical course and the pathological features of EAE is combined with the modulation of chemokines levels expressed in the inflamed CNS. NPCs were isolated from brains of neonatal C57/Bl6 mice and were subcutaneously administered in female mice with myelin oligodendrocyte glycoprotein (MOG)-induced EAE. Clinical signs of the disease and transcript analysis of the CNS in the acute phase were performed. In addition, the presence of inflammatory components in the spinal cord was evaluated and ex vivo proliferation of lymphocytes was measured. NPC recipients exhibited ameliorated clinical outcome and less pronounced pathological features in their spinal cord. Downregulation of chemokine mRNA levels throughout the CNS was correlated with diminished Mac-3-, CD3-, and CD4-positive cells and reduced expression levels of antigen-presenting molecules in the spinal cord. Moreover, NPC transplantation resulted in lymphocyte-related, although not splenocyte- related, peripheral immunosuppression. We conclude that NPCs ameliorated EAE potentially by modulating the levels of chemokines expressed in the inflamed CNS, thus resulting in the impaired recruitment of immune cells. These findings further contribute to the better understanding of NPCs’ immunomodulatory properties in neuroinflammatory disorders, and may lead to faster translation into potential clinical use.
Notes: Correspondence: Nikolaos Grigoriadis, M.D., Ph.D., Laboratory of Experimental Neurology and Neuroimmunology, B’ Dept. of Neurology, AHEPA University Hospital, Stilp. Kyriakides 1, 54636 – Thessaloniki, Central Macedonia, Greece. Telephone: 0030-231-0994665; E-Mail: grigoria@med.auth.gr
URI: http://hdl.handle.net/1942/20251
DOI: 10.5966/sctm.2015-0068
ISI #: 000367424500015
ISSN: 2157-6564
Category: A1
Type: Journal Contribution
Validation: ecoom, 2017
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
N/A2.64 MBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.